Welcome

From the latest health and nutrition solutions to making an impact on people and the planet, check out our top stories. To contact our U.S. media relations team, please email nhscusmedia@us.nestle.com

All Stories Press Releases Product News Our People Diversity, Equity and Inclusion Innovation Sustainability Community Impact

Nature's Bounty

NATURE’S BOUNTY® REDEFINES QUALITY SLEEP WITH ITS NEW TRIPLE-ACTION SLEEP3 GUMMIES

June 06, 2023

Orgain

Alex Morgan Teams Up with Orgain to Help Fuel Her Journey to Compete in The World’s Largest Women’s Soccer Event

June 06, 2023

Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST

Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection

June 05, 2023

Nature's Bounty

NATURE’S BOUNTY® UNVEILS NEW OPTIONS FOR WOMEN SEARCHING FOR HAIR LOSS AND WEIGHT MANAGEMENT PRODUCTS WITH CLINICALLY RESEARCHED INGREDIENTS

May 16, 2023

Vowst Announcement Press Release

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™ a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

May 08, 2023

Vowst AnnouncementPress Release

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

April 26, 2023

Send a media inquiry

Connect with our Media Relations team.